Rating Change
BTIG analysts reiterated a Buy rating on vTv Therapeutics Inc. (NASDAQ:VTVT) on July 16, 2026.
reiterateNASDAQ:VTVT
BTIG Reiterates Buy Rating on vTv Therapeutics Inc. (VTVT)
Rating Change BTIG analysts reiterated a Buy rating on vTv Therapeutics Inc. (NASDAQ:VTVT) on July 16, 2026. Market Context vTv Therapeutics Inc.
Market Context
vTv Therapeutics Inc. operates in the Healthcare sector. The stock currently trades at $32.29 with a market capitalization of $90.3M.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for vTv Therapeutics Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for vTv Therapeutics Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 16, 2026 | BTIG | Buy | N/A |
| Mar 12, 2026 | Evercore ISI Group | Outperform | N/A |
| Mar 11, 2026 | BTIG | Buy | N/A |
| Jan 27, 2026 | BTIG | Buy | N/A |
| Jan 23, 2026 | Roth Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View VTVT Stock Page
Frequently Asked Questions
What does a Buy rating mean for VTVT?
A Buy rating from BTIG reflects the analyst's outlook on vTv Therapeutics Inc. (NASDAQ:VTVT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the VTVT forecast page.